Clin2
NCT07392125Likely a fitNot yet recruiting

Study of cytisinicline to help adults stop vaping

Vaping Cessation

Treatments studied

This trial tests a medication called cytisinicline to see if it helps adults quit vaping nicotine e-cigarettes. Participants will take the medicine and receive behavioral support to stop vaping.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
800 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You vape nicotine e-cigarettes every day and have tried to quit before but failed.
  • You are willing to set a quit date between 7 and 14 days after starting the study.
  • You do not currently smoke or use any other tobacco or nicotine products (like cigarettes, cigars, or nicotine pouches), and haven't for at least 3 months.
  • You are not using cannabis (marijuana) by smoking or vaping, and haven't for at least 4 weeks.
  • You are not pregnant, breastfeeding, or planning to become pregnant, and agree to use birth control if needed.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06617312Recruiting· Phase 2
Cytisinicline and brain response to smoking cues

This study tests how a medicine called cytisinicline (similar to a plant-based stop-smoking aid) affects brain activity when you see or think about smoking. It may help researchers understand how the medicine works, even if you aren't ready to quit right now.

Los Angeles, California
NCT07274475Not yet recruiting
Smoking harm reduction with e-cigarettes and cytisine

This study tests if using e-cigarettes or the medication cytisine can help people who smoke 5 or more cigarettes a day reduce smoking-related harm. You'll be followed for one year.

NCT07040566Recruiting· Phase 2
Varenicline to help stop vaping

This trial tests whether varenicline, a medicine that reduces cravings, can help people quit using e-cigarettes that contain nicotine. You must be a daily nicotine vaper and live in Connecticut or South Carolina.

New Haven, Connecticut
NCT06579846Not yet recruiting· Phase 4
Exercise and Cytisinicline for Quitting Smoking: 12-Month Study

This study tests whether a combination of exercise and a medication called cytisinicline (a plant-based pill that helps reduce cravings) can help you quit smoking for a full year. You would receive both treatments and be monitored for 12 months.

NCT06474299Recruiting· Phase 4
Quit Smoking and Vaping With Patches and Pills

This study tests whether a combination of a nicotine patch plus a medication called varenicline can help people who both smoke and vape quit both. You'll get free medication and support to help you stop.

Madison, Wisconsin
NCT07786896Not yet recruiting· Phase 4
Quitting vaping with nicotine replacement therapy

This study tests whether nicotine replacement therapy (like patches or gum) helps people who regularly vape nicotine stop vaping. If you're interested in quitting in the next few months, this study may be able to support you.

Greenville, North Carolina

Hear when a new Vaping Cessation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.